Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05408104 · ClinicalTrials.gov registry record
Postoperative Tolvaptan Use in Left Ventricular Assist Device Implantation Patients
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 28
- Enrollment target
NCT05408104 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 28 participants.
The verdict
NCT05408104 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
This research study will compare two standard of care approaches for managing low sodium levels in heart failure patients with Left Ventricular Assist Device (LVAD). The study will compare the outcomes of LVAD patients with low sodium levels who take Tolvaptan to those who do not take Tolvaptan. Tolvaptan is FDA approved for use in the study population and is commonly used to treat low sodium levels in heart failure and LVAD patients. It is not known if taking Tolvaptan or not taking Tolvaptan is better at improving outcomes in newly implanted LVAD patients with low sodium levels. By doing this study, the Principal Investigator (PI) hopes to learn which is better at improving outcomes.
Interventions
- DRUG tolvaptan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-03-28 |
| Est. Completion | 2022-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05408104
The ClinicalTrials.gov registry entry for NCT05408104 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tolvaptan is the first listed.
NCT05408104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05408104 about?
NCT05408104 is a clinical study titled "Postoperative Tolvaptan Use in Left Ventricular Assist Device Implantation Patients". This research study will compare two standard of care approaches for managing low sodium levels in heart failure patients with Left Ventricular Assist Device (LVAD). The study will compare the outcomes of LVAD patients with low sodium levels who take Tolvaptan to those who do not take Tolvaptan. Tol...
What is the current status of trial NCT05408104?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2019-03-28. Estimated completion is 2022-05-01.
What interventions are being tested in trial NCT05408104?
The interventions under investigation include: tolvaptan (DRUG).
Who is sponsoring clinical trial NCT05408104?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.